Will the Dong Wha Pharm’s ‘Zabolante’ lead the antibiotic market?

The Dong Wha Pharm’s quinolones- type antibiotic, ‘Zabolante (zabofloxacin)’, which acquired a new drug approval from the Ministry of Food and Drug Safety on 20 March, has attracted attention of the industry. Although the size of the market has increased 6% up annually at approximately KRW 120 billion, it is occupied by foreign drugs.

Thus, the pharmaceutical industry has high expectation on t...